ArticleBMC psychiatry2025
The association between gamma-aminobutyric acid levels and suicidal behavior in depression.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Investigating genetic overlap of multidimensional pain and suicidal behaviors in >2 million individuals.Research square · 2026Article
- A human-derived Bacteroides strain attenuates depressive-like behavior in a rat model of social defeat-induced stress.BMC medicine · 2026Article
- Brain Network Controllability and Its Regional Gene Expression Profile Associated With Suicidal Tendencies in Major Depressive Disorder Patients.Depression and anxiety · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThe present investigation was designed to probe into the relationship between fluctuations in gamma - aminobutyric acid (GABA) levels and depression accompanied by suicidal behavior. It aimed to explore the potential mechanistic role of GABA in the suicide risk among patients with depression and appraise its potential as a biomarker.
methodsThis study employed a single - center, prospective, cross - sectional design. A total of 106 subjects were enrolled and allocated into three groups: an experimental group (patients with depression and suicidal behavior, n = 36), a control group (patients with depression but without suicidal behavior, n = 40), and a healthy control group (n = 30). Serum GABA levels were quantified, and evaluations were conducted using the Hamilton Depression Scale (HAMD), the Beck Scale for Suicide Ideation (BSS), serum cortisol levels, and brain - derived neurotrophic factor (BDNF) levels.
resultsThe serum GABA level was significantly lower in the experimental group (2.50 ± 0.40 µmol/L) compared to both the control group (3.00 ± 0.30 µmol/L, p < 0.01) and the healthy control group (3.50 ± 0.20 µmol/L, p < 0.01). Conversely, serum cortisol levels were markedly elevated in the experimental group (601.18 ± 79.86 nmol/L, p < 0.01), while BDNF levels were substantially reduced (15.0 ± 3.0 ng/mL, p < 0.01). Psychological assessment scores showed that the experimental group had the highest levels of depressive symptoms and suicidal ideation, with significantly elevated HAMD and BSS scores (p < 0.001). Correlation analyses revealed that serum GABA levels were negatively correlated with BSS scores (r = -0.8444, p < 0.001), HAMD scores (r = -0.7850, p < 0.001), and cortisol levels (r = -0.6427, p < 0.001), but positively correlated with BDNF levels (r = 0.6784, p < 0.001).
conclusionA significant reduction in serum GABA levels is closely associated with increased depressive severity and suicide risk. These findings suggest that GABA plays a key role in the pathophysiology of depression and suicidal behavior, potentially through modulation of the HPA axis and neuroplasticity mechanisms. Serum GABA serves as a valuable biomarker for assessing suicide risk and represents a promising target for future therapeutic interventions in depression-related suicidality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.